Literature DB >> 9353089

Granuloma inguinale (donovanosis): an unusual cause of otitis media and mastoiditis in children.

D Govender1, K Naidoo, R Chetty.   

Abstract

Granuloma inguinale (donovanosis) is seen predominantly in adults (it rarely occurs in children) and mainly affects genital skin and mucosa. Infection occurs at other skin and mucosal sites, and hematogenous dissemination to bone also has been described. The infection responds dramatically to appropriate antibiotic treatment. We present two cases of granuloma inguinale occurring in children (8 months and 5 months of age) causing mastoiditis and external ear discharges. A temporal lobe abscess also developed in the 8-month-old child. Subsequent computed tomography scans showed marked improvement in the brain lesion after treatment. The second child had a polypoid mass in the middle ear that on biopsy showed the features of granuloma inguinale. The mother of this child had biopsy-proven granuloma inguinale of the uterine cervix. These cases indicate that granuloma inguinale can be transmitted during vaginal delivery, and careful cleansing of neonates born to infected mothers is recommended.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353089     DOI: 10.1093/ajcp/108.5.510

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

Review 1.  Donovanosis.

Authors:  N O'Farrell
Journal:  Sex Transm Infect       Date:  2002-12       Impact factor: 3.519

2.  Donovanosis.

Authors:  Walter Belda Junior
Journal:  An Bras Dermatol       Date:  2020-09-17       Impact factor: 1.896

3.  Granuloma inguinale in a mentally retarded girl.

Authors:  Murugan Sankaranantham
Journal:  Indian J Sex Transm Dis AIDS       Date:  2020-07-31

4.  Brazilian Protocol for Sexually Transmitted Infections, 2020: infections that cause genital ulcers.

Authors:  Mauro Cunha Ramos; José Carlos Sardinha; Herculano Duarte Ramos de Alencar; Mayra Gonçalves Aragón; Leonor Henriette de Lannoy
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.